<SEC-DOCUMENT>0001140361-22-018318.txt : 20220509
<SEC-HEADER>0001140361-22-018318.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509162436
ACCESSION NUMBER:		0001140361-22-018318
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Quantum-Si Inc
		CENTRAL INDEX KEY:			0001816431
		STANDARD INDUSTRIAL CLASSIFICATION:	MEASURING & CONTROLLING DEVICES, NEC [3829]
		IRS NUMBER:				851388175
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-263514
		FILM NUMBER:		22905406

	BUSINESS ADDRESS:	
		STREET 1:		530 OLD WHITFIELD STREET
		CITY:			GUILFORD
		STATE:			CT
		ZIP:			06437
		BUSINESS PHONE:		(203) 458-7100

	MAIL ADDRESS:	
		STREET 1:		530 OLD WHITFIELD STREET
		CITY:			GUILFORD
		STATE:			CT
		ZIP:			06437

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HighCape Capital Acquisition Corp.
		DATE OF NAME CHANGE:	20200629
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>brhc10037213_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Filed Pursuant to Rule 424(b)(3)<br>
        Registration No. 333-257676</div>
      <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-weight: bold;">333-263514</div>
      <div style="text-indent: -10.8pt; margin-right: 64.8pt; margin-left: 421.2pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</div>
      <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">PROSPECTUS SUPPLEMENT NO. 2</div>
      <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">To Prospectus dated March 3, 2022</div>
      <div style="margin-right: 240.45pt; margin-left: 230.4pt;"> <br>
      </div>
      <div style="text-align: center;"><img width="171" height="35" src="image01.jpg"></div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">QUANTUM-SI INCORPORATED</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Up to 78,841,853 Shares of Class A Common Stock</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Up to 19,937,500 Shares of Class B Common Stock</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Up to 135,000 Warrants</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">&#160;</div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">This prospectus supplement no. 2 supplements the prospectus dated March 3, 2022 (the &#8220;Prospectus&#8221;) relating to the issuance by us of up to an aggregate of 3,968,319 shares
        of our Class A common stock, par value $0.0001 per share (&#8220;Class A common stock&#8221;), which consists of (i) up to 135,000 shares of Class A common stock that are issuable upon the exercise of private placement warrants (the &#8220;Private Placement
        Warrants&#8221;) originally issued in a private placement in connection with the initial public offering of our predecessor company, HighCape Capital Acquisition Corp., a Delaware corporation (&#8220;HighCape&#8221;), at an exercise price of $11.50 per share of
        Class A common stock, and (ii) up to 3,833,319 shares of Class A common stock that are issuable upon the exercise of 3,833,319 warrants issued in connection with the initial public offering of HighCape (the &#8220;Public Warrants,&#8221; and together with the
        Private Placement Warrants, the &#8220;Warrants&#8221;).</div>
      <div><br>
      </div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">On June 10, 2021, HighCape consummated a business combination (the &#8220;Business Combination&#8221;) pursuant to the terms of the Business Combination Agreement, dated as of February
        18, 2021 (the &#8220;Business Combination Agreement&#8221;), by and among HighCape, Tenet Merger Sub, Inc., a Delaware corporation, and Quantum-Si Incorporated, a Delaware corporation (&#8220;Legacy Quantum-Si&#8221;). Immediately upon the consummation of the Business
        Combination and the other transactions contemplated by the Business Combination Agreement, Merger Sub merged with and into Legacy Quantum-Si, with Legacy Quantum-Si surviving the Business Combination as a wholly-owned subsidiary of HighCape (the
        &#8220;Merger&#8221;). In connection with the Business Combination, HighCape changed its name to &#8220;Quantum-Si Incorporated&#8221; and Legacy Quantum-Si changed its name to &#8220;Q-SI Operations Inc.&#8221;&#160;</div>
      <div><br>
      </div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">The Prospectus and prospectus supplements also relate to the resale from time to time by the Selling Securityholders named in the Prospectus (the &#8220;Selling Securityholders&#8221;)
        of up to (i) 135,000 Private Placement Warrants, (ii) 135,000 shares of Class A common stock that may be issued upon exercise of the Private Placement Warrants, (iii) 2,583,750 shares of Class A common stock held by HighCape&#8217;s sponsor, HighCape
        Capital Acquisition LLC (the &#8220;Sponsor&#8221;) and certain of its transferees (the &#8220;Founder Shares&#8221;), (iv) <font style="color: #000000;">21,964,456 </font>shares of Class A common stock issued in a private placement in connection with the closing of the
        Business Combination, (v)&#160;696,250 shares of Class&#160;A common stock issued in a private placement to certain affiliates of Foresite Capital Management, LLC in connection with the closing of the Business Combination, (vi) <font style="color: #000000;">49,629,078</font>
        shares of Class A common stock issued to our directors, officers and affiliates and the directors, officers and affiliates of Legacy Quantum-Si pursuant to the Business Combination Agreement, including shares of Class A common stock that may be
        issued upon the exercise of stock options (the &#8220;Options&#8221;) and the vesting of restricted stock units or upon the conversion of Class B common stock, par value $0.0001 per share (&#8220;Class B common stock&#8221;), and (vii) 19,937,500 shares of Class B common
        stock issued pursuant to the Business Combination Agreement.</div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">&#160;</div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">The Prospectus provides you with a general description of such securities and the general manner in which we and the Selling Securityholders may offer or sell the
        securities. More specific terms of any securities that we and the Selling Securityholders may offer or sell may be provided in a prospectus supplement that describes, among other things, the specific amounts and prices of the securities being
        offered and the terms of the offering. The prospectus supplement may also add, update or change information contained in the Prospectus.</div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">&#160;</div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">We will not receive any proceeds from the sale of shares of Class A common stock, shares of Class B common stock or Private Placement Warrants by the Selling
        Securityholders or of shares of Class A common stock by us pursuant to the Prospectus, except with respect to amounts received by us upon exercise of the Warrants or the Options. However, we will pay the expenses, other than any underwriting
        discounts and commissions, associated with the sale of securities pursuant to the Prospectus.</div>
      <div style="font-family: 'Times New Roman', Times, serif;">&#160;</div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">We registered the securities for resale pursuant to the Selling Securityholders&#8217; registration rights under certain agreements between us and the Selling Securityholders.
        Our registration of the securities covered by the Prospectus does not mean that either we or the Selling Securityholders will issue, offer or sell, as applicable, any of the securities. The Selling Securityholders may offer and sell the securities
        covered by the Prospectus in a number of different ways and at varying prices. We provide more information about how the Selling Securityholders may sell the shares or Warrants in the section entitled &#8220;Plan of Distribution&#8221; in the Prospectus.</div>
      <div style="text-indent: 36pt; margin-right: 36pt; margin-left: 36pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after:always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">This prospectus supplement incorporates into the Prospectus the information contained in our attached current report on Form 8&#8209;K <font style="color: #000000;">(except for
          the information furnished under Item 2.02, which is not incorporated into the Prospectus)</font>, which was filed with the Securities and Exchange Commission on May 9, 2022.</div>
      <div style="text-indent: 36pt; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', Times, serif;">&#160;</div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">You should read this prospectus supplement in conjunction with the Prospectus, including any supplements and amendments thereto. This prospectus supplement is qualified by
        reference to the Prospectus except to the extent that the information in the prospectus supplement supersedes the information contained in the Prospectus. This prospectus supplement is not complete without, and may not be delivered or utilized
        except in connection with, the Prospectus, including any supplements and amendments thereto.</div>
      <div style="text-indent: 36pt; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', Times, serif;">&#160;</div>
      <div style="text-indent: 18pt; font-family: 'Times New Roman', Times, serif;">Our Class A common stock and Public Warrants are listed on Nasdaq under the symbols &#8220;QSI&#8221; and &#8220;QSIAW,&#8221; respectively. On May 6, 2022, the closing price of our Class A common
        stock was $3.96 and the closing price of our Public Warrants was $0.79.</div>
      <div style="text-indent: 36pt; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', Times, serif;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Investing in our securities involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 12 of the Prospectus and in the other documents that
        are incorporated by reference in the Prospectus.</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this
        prospectus supplement of the Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">The date of this prospectus supplement is May 9, 2022.</div>
      <div style="text-align: center;"> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div id="DSPFiXBRLHidden" style="display: none;">false000181643100018164312022-05-052022-05-050001816431us-gaap:CommonClassAMember2022-05-052022-05-050001816431qsi:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember2022-05-052022-05-05</div>
        <div>
          <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
          <div>
            <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
            <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
            <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
            <div><br>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">FORM 8-K</div>
            <div><br>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CURRENT REPORT</div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Pursuant to Section 13 OR 15(d) of the</div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Securities Exchange Act of 1934</div>
            <div><br>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">Date of Report (Date of earliest event reported): <font style="font-weight: bold;">May 5, 2022</font></div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;"> <br>
              </font></div>
            <div>
              <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"></div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold;">QUANTUM-SI INCORPORATED<br>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(Exact name of registrant as specified in its charter)</div>
            <div><br>
            </div>
            <div>
              <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"></div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5e8d0c8914d143da85790852126c25b2">

                <tr>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Delaware<br>
                    </div>
                  </td>
                  <td style="width: 34%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">001-39486<br>
                    </div>
                  </td>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">85-1388175<br>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(State or other jurisdiction of incorporation)</div>
                  </td>
                  <td style="width: 34%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(Commission File Number)</div>
                  </td>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(IRS Employer</div>
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">Identification No.)</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 33%; vertical-align: top;">&#160;</td>
                  <td style="width: 34%; vertical-align: top;">&#160;</td>
                  <td style="width: 33%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">530 Old Whitfield Street<br>
                    </div>
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Guilford, Connecticut</div>
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(Address of principal executive offices)</div>
                  </td>
                  <td style="width: 34%; vertical-align: top;">&#160;</td>
                  <td style="width: 33%; vertical-align: bottom; text-align: center;">
                    <div style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">06437<br>
                    </div>
                    <div style="font-family: 'Times New Roman',Times,serif;">(Zip Code)</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">Registrant&#8217;s telephone number, including area code: <font style="font-weight: bold;">(203) 458-7100</font></div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;"> <br>
              </font></div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">N/A</div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(Former name or former address, if changed since last report)</div>
            <div><br>
            </div>
            <div>
              <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"></div>
            <div><br>
            </div>
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
              provisions:</div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1194495d91af4ed2a55056b82e21d1e7">

                <tr>
                  <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9fbc3c4da9c24e2cb61e64221e13a867">

                <tr>
                  <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4f4c76a9a50b4463bb2db992e263c2e3">

                <tr>
                  <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z59691e96b3e2467d9b5026a63375a8c2">

                <tr>
                  <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="font-family: 'Times New Roman', Times, serif;">Securities registered pursuant to Section 12(b) of the Act:</div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd64c37d9b44e4645b4f82730219fca99">

                <tr>
                  <td style="width: 39.17%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Title of each class</div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Trading Symbol(s)</div>
                  </td>
                  <td style="width: 2.16%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 30.34%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Name of each exchange on<br>
                      which registered</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 39.17%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Class A common stock, par value $0.0001 per share<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: top;">&#160;</td>
                  <td style="width: 27%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">QSI<br>
                    </div>
                  </td>
                  <td style="width: 2.16%; vertical-align: top;">&#160;</td>
                  <td style="width: 30.34%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">The Nasdaq Stock Market LLC<br>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 39.17%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: top;">&#160;</td>
                  <td style="width: 27%; vertical-align: top;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">QSIAW<br>
                    </div>
                  </td>
                  <td style="width: 2.16%; vertical-align: top;">&#160;</td>
                  <td style="width: 30.34%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">The Nasdaq Stock Market LLC<br>
                    </div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule
              12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>
            <div><br>
            </div>
            <div style="text-align: right; font-family: 'Times New Roman', Times, serif;">Emerging growth company&#160;&#160; &#9744;</div>
            <div><br>
            </div>
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
              financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</div>
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif;"> <br>
            </div>
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif;">
              <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
              <div> </div>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="page-break-after:always;" class="DSPFPageBreak">
                <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze245a147cd6844578d9af5c199d77ea8">

                <tr>
                  <td style="width: 72pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 2.02.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Results of Operations and Financial Condition.</div>
                  </td>
                </tr>

            </table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">On May 9, 2022, Quantum-Si Incorporated (the &#8220;Company&#8221;) issued a press release announcing its results for the first quarter ended March 31, 2022
              and providing a business update. A copy of the press release is furnished as Exhibit 99.1 hereto.</div>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the
              Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
              Exchange Act, except as expressly set forth by specific reference in such a filing.</div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1cfef43a6c4d4382b643d24d704efa2f">

                <tr>
                  <td style="width: 72pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 5.02.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Departure&#160;of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
                      Officers.</div>
                  </td>
                </tr>

            </table>
            <div>
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;"><font style="font-style: italic;">&#160;</font>&#160;</div>
            </div>
            <div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">On May 5, 2022, the Board of Directors (the &#8220;Board&#8221;) of the Company approved a title change for Michael P. McKenna, Ph.D., from President and
                Chief Operating Officer of the Company to Executive Vice President, Product Development and Operations of the Company, effective as of May 6, 2022. In addition, on May 9, 2022, the Company announced that Patrick Schneider was appointed by
                the Board as President and Chief Operating Officer of the Company, effective as of May 9, 2022.</div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;</div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">Dr. Schneider, age 54, has served in a number of roles at MilliporeSigma, including its predecessor entities (the life science business of Merck
                KGaA, Darmstadt, Germany), most recently as Senior Vice President, Strategy, Business Development and Innovation, and Chair of the Life Science Innovation Board from 2016 until April 2022, where he led strategy development, business
                development, and licensing for a global team of biologists, chemists and engineers. Prior to that, between 2006 to 2015, Dr. Schneider served as Vice President of the Bioscience Business Unit, Vice President of Research Content and Reagents
                Business, General Manager of New Business Initiatives R&amp;D and Business Development, and Vice President of Research Reagents Business Unit and Vice President of R&amp;D and Manufacturing. From 2003 to 2006, Dr. Schneider served as Vice
                President of Research &amp; Development, Business Development &amp; Scientific Affairs at Serologicals, Inc. Dr. Schneider was also the Co-Founder and Gene Discovery Group Leader at Reprogen, Inc. Dr. Schneider received his Ph.D. in biology
                from University of California, Irvine, and his B.S. in microbiology from Northern Arizona University.</div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;</div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">The selection of&#160;Dr. Schneider to perform the functions of President and Chief Operating Officer was not pursuant to any arrangement or
                understanding between Dr. Schneider and any other person. There are no family relationships between&#160;Dr. Schneider&#160;and any director or executive officer of the Company, and there are no transactions between&#160;Dr. Schneider&#160;and the Company that
                would be required to be reported under Item 404(a) of Regulation S-K.</div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;</div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">On April 26, 2022, the Company entered into an offer letter of employment with Dr. Schneider, effective as of May 9, 2022 (the&#160;&#8220;Offer Letter&#8221;).
                Pursuant to the terms of the Offer Letter, Dr. Schneider&#8217;s annual base salary is $475,000. Dr. Schneider is eligible to receive an annual discretionary bonus with a target of 75% of his base salary. Dr. Schneider will receive a one-time
                sign-on bonus in the amount of $400,000, which is recoverable in full by the Company in the event that Dr. Schneider voluntarily terminates his employment with the Company prior to the 12 month anniversary of his start date. The Offer
                Letter further provides that Dr. Schneider will receive an award of 1,000,000 stock options to purchase shares of Class A common stock of the Company (&#8220;Class A common stock&#8221;) on his start date, with 25% of the stock options to vest on the
                last day of the calendar quarter of the one-year anniversary of his start date, and 2.08% to vest monthly at the end of each month thereafter. In addition, the Offer Letter provides that Dr. Schneider will receive an award of 500,000
                performance-based stock options to purchase shares of Class A common stock on his start date, which will vest in full if within two years of his start date the Class A common stock closing price is at least $10.00 (as adjusted) for 20 out
                of 30 consecutive trading days. In addition, the Offer Letter provides that Dr. Schneider will receive an award of 500,000 performance-based stock options to purchase shares of Class A common stock on his start date, which will vest in full
                if within four years of his start date the Class A common stock closing price is at least $20.00 (as adjusted) for 20 out of 30 consecutive trading days. Commencing on his start date, Dr. Schneider will become a participant in the Company&#8217;s
                Executive Severance Plan, as amended. The foregoing description of the Offer Letter is not complete and is qualified in its entirety by reference to the full text of the Offer Letter, a copy of which is filed as Exhibit 10.1 to this Current
                Report on Form 8-K.</div>
            </div>
            <div>
              <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            </div>
            <div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">Further, in connection with Dr. Schneider&#8217;s appointment, Dr. Schneider and the Company entered into an indemnification agreement in the form the
                Company has entered into with its other executive officers, which form is filed as Exhibit 10.16 to the Company&#8217;s Current Report on Form 8-K, filed with the U.S. Securities and Exchange Commission on June 15, 2021.</div>
            </div>
            <div>
              <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;&#160;</div>
            </div>
            <div>
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif;">A copy of the press release announcing Dr. Schneider&#8217;s appointment is attached hereto as Exhibit 99.2 and incorporated herein by reference.</div>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="page-break-after:always;" class="DSPFPageBreak">
                <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z257071c4feff4b18aa79f4f7c5cdf648">

                <tr>
                  <td style="width: 72pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 9.01</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Financial Statements and Exhibits.</div>
                  </td>
                </tr>

            </table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd19a6ce045fb4f6f8f3cb0e7b287e1dc">

                <tr>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(d)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Exhibits.</div>
                  </td>
                </tr>

            </table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaed58fefc1864970ad8af8873c9e09aa">

                <tr>
                  <td style="width: 10.18%; vertical-align: top; border-bottom: #000000 2px solid; white-space: nowrap;">
                    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Exhibit<br>
                      No.</div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">
                    <div style="font-family: 'Times New Roman', Times, serif;">&#160;</div>
                  </td>
                  <td style="width: 88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Description</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 10.18%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif;">10.1</div>
                  </td>
                  <td style="width: 2%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                    <div style="font-family: 'Times New Roman', Times, serif;">&#160;</div>
                  </td>
                  <td style="width: 88%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Offer Letter of Employment, dated April 26, 2022, by and between Quantum-Si Incorporated and Patrick Schneider</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 10.18%; vertical-align: middle;">
                    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif;">99.1</div>
                  </td>
                  <td style="width: 2%; vertical-align: middle;">&#160;</td>
                  <td style="width: 88%; vertical-align: middle;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Press Release dated May 9, 2022</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 10.18%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif;">99.2</div>
                  </td>
                  <td style="width: 2%; vertical-align: middle; background-color: rgb(204, 238, 255);">&#160;</td>
                  <td style="width: 88%; vertical-align: middle; background-color: rgb(204, 238, 255);">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Press Release dated May 9, 2022</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 10.18%; vertical-align: middle;">
                    <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif;">104</div>
                  </td>
                  <td style="width: 2%; vertical-align: middle;">&#160;</td>
                  <td style="width: 88%; vertical-align: middle;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="page-break-after:always;" class="DSPFPageBreak">
                <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div><br>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">SIGNATURES</div>
            <div><br>
            </div>
            <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
              undersigned hereunto duly authorized.</div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z3707d9c821aa4ab0ae0060ac74b4da06">

                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">QUANTUM-SI INCORPORATED</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div style="font-family: 'Times New Roman', Times, serif;">By:</div>
                  </td>
                  <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="font-family: 'Times New Roman', Times, serif;">/s/ Claudia Drayton</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Name:</div>
                  </td>
                  <td style="width: 45%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Claudia Drayton</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Title:</div>
                  </td>
                  <td style="width: 45%; vertical-align: top;">
                    <div style="font-family: 'Times New Roman', Times, serif;">Chief Financial Officer</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="font-family: 'Times New Roman', Times, serif;">Date:&#160; May 9, 2022</div>
            <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div id="DSPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div>
              <div>
                <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
                <div>
                  <div style="text-align: right; font-weight: bold;">Exhibit 10.1</div>
                  <div style="text-align: right; font-weight: bold;"> <br>
                  </div>
                  <div>
                    <table cellspacing="0" cellpadding="0" border="0" id="zee19f861d89e4122a1f70a117b12027a" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                        <tr>
                          <td style="width: 50.00%;">
                            <div>&#160;</div>
                          </td>
                          <td style="width: 50.00%;">
                            <div>&#160;April 26, 2022</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">Patrick Schneider</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">Dear Patrick:</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">On behalf of Quantum-Si, I am pleased to offer you the position as <font style="font-style: italic;">President and Chief Operating Officer </font>beginning no later than June 1,
                    2022.&#160; You will report to the Quantum-Si CEO.&#160; Your annualized compensation in this position will consist of an annual base salary of $475,000 paid in twice monthly pay periods, less required deductions.</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">Beginning with the 2022 calendar year, you will be considered for an annual discretionary bonus targeted at 75% of your annual base salary.&#160; At the end of each calendar year, the
                    Board of Directors will establish performance goals and targets for the following year, with the expectation that your bonus calculation will be based 80% on company goals and 20% on personal goals.&#160; Such bonus shall be paid no later
                    than March 31 of the following calendar year, and it will be a condition of your eligibility to receive any bonus that you remain employed with Quantum-Si through the scheduled date of payment of such bonuses.&#160; With respect to your
                    bonus for the 2022 calendar year, such bonus will be prorated based on your start date and based on established performance goals and targets for the remainder of 2022, with the possibility of a bonus that exceeds 100% of the prorated
                    target bonus in the discretion of the Board of Directors if certain revenue targets are achieved.</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">You will receive a one-time taxable sign on bonus of $400,000.&#160; One half of that amount will be paid to you in the first available payroll date after your start date.&#160; The second half
                    of the amount will be paid to you 6 months following your start date in the next available payroll date.&#160; Such payments will be recoverable in full by the company in the event you voluntarily terminate your employment or are terminated
                    for &#8220;cause&#8221; (as defined in the Quantum-Si Incorporated Executive Severance Plan) prior to 12 months from your start date<font style="font-style: italic;">.</font></div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">In addition to the outlined cash compensation, you will receive 1,000,000 stock options (&#8220;Time-Based Options&#8221;) in Quantum-Si that (i) will be subject to the approval of Quantum-Si&#8217;s
                    Compensation Committee, (ii) will be subject to the terms of the grant documents therefore, (iii) subject to continued service and the specific terms of your grant, will vest over a four year period with the following schedule: 25% on
                    the last day of the calendar quarter of the one year anniversary of your start date, and 2.083% at the end of each month thereafter.</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">You will also receive 500,000 stock options (&#8220;$10 Performance Options&#8221;) in Quantum-Si that (i) will be subject to the approval of Quantum-Si&#8217;s Compensation Committee, (ii) will be
                    subject to the terms of the grant documents therefore, (iii) subject to continued service and the specific terms of your grant, will vest in full if within two years of your start date Quantum-Si&#8217;s common stock closing price is at least
                    $10.00 (as adjusted) for 20 out of 30 consecutive trading days.&#160; In addition, you will receive 500,000 stock options (&#8220;$20 Performance Options&#8221;) in Quantum-Si that (i) will be subject to the approval of Quantum-Si&#8217;s Compensation
                    Committee, (ii) will be subject to the terms of the grant documents therefore, (iii) subject to continued service and the specific terms of your grant, will vest in full if within four years of your start date Quantum-Si&#8217;s common stock
                    closing price is at least $20.00 (as adjusted) for 20 out of 30 consecutive trading days.&#160; Further, you will be eligible for, but not guaranteed to receive, an annual time-based equity award in March 2023.</div>
                  <div>&#160;</div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">You will be eligible for participation in the Quantum-Si Incorporated Executive Severance Plan, and you will become a participant in such Executive Severance Plan commencing on your
                    start date.</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">You will be based out of Quantum-Si&#8217;s San Diego, California facility, with the expectation that you will travel regularly, as appropriate and as requested by the Board, to the
                    Company&#8217;s offices in Connecticut.</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">Quantum-Si recognizes the need for employees to take time away from the office to creatively recharge.&#160; We also believe in taking personal responsibility for managing our own time,
                    workload and results.&#160; For these reasons our Flexible Paid Time Off (FPTO) policy affords eligible employees the flexibility to be given an indeterminate amount of paid time off from work for vacation, personal or family obligations and
                    other personal requirements, subject to the requirements of the policy, including advance notice and prior approval in Quantum-Si&#8217;s discretion.&#160; In no event will any employee be compensated for unused vacation time.&#160; You will also be
                    eligible to participate in medical and other benefit plans in accordance with the rules and eligibility of those plans currently in effect.&#160; Health insurance shall commence on your start date.&#160; Further, while we expect you to remain
                    with Quantum-Si for a long time, this letter is not an employment contract and you will be an at-will employee.</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">This letter is subject to successful completion of a background check and satisfactory completion of references.&#160; By signing this letter, you authorize Quantum-Si to conduct such
                    background check.</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">Quantum-Si considers the protection of its confidential information, proprietary materials and goodwill to be extremely important.&#160; As a condition of this offer of employment, you are
                    required to sign Quantum-Si&#8217;s Non-solicit, Confidentiality and Intellectual Property Agreement, and other policies contained in the Company&#8217;s Employee Handbook.</div>
                  <div>&#160;</div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">We appreciate your exceptional talent and are very excited about you joining our growing and dynamic team at Quantum-Si.&#160; We firmly believe that Quantum-Si offers a unique combination
                    of emotional, intellectual, and interpersonal stimulation that will be truly enjoyable.&#160; As a member of our growing team, you will be in the rare position of helping to shape the culture and direction of our organization.&#160; We have
                    tremendous opportunities ahead of us, and I am confident you have the expertise required to help us achieve our objectives.&#160; If you have any questions regarding this offer, the position, or the company&#8217;s benefits programs, please do not
                    hesitate to reach out.</div>
                  <div>&#160;</div>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                    <div style="page-break-after:always;" id="DSPFPageBreak">
                      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                  </div>
                  <div style="text-align: justify; color: rgb(0, 0, 0);">&#160;Please note that this offer will expire on April 29, 2022, unless accepted by you in writing prior to such date.</div>
                  <div>&#160;</div>
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdeedb0a888444afdaa6e23f5606367a7">

                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                        <td colspan="2" style="vertical-align: top;">
                          <div style="color: rgb(0, 0, 0);">Sincerely,</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                        <td colspan="2" style="vertical-align: top;">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                        <td colspan="2" style="vertical-align: top;">
                          <div style="color: rgb(0, 0, 0);">Quantum-Si Incorporated</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                        <td style="width: 45%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                          <div style="color: rgb(0, 0, 0);">By:</div>
                        </td>
                        <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                          <div style="color: rgb(0, 0, 0);">/s/ Jonathan M. Rothberg</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">
                          <div style="color: rgb(0, 0, 0);">Jonathan M. Rothberg</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">
                          <div style="color: rgb(0, 0, 0);">Executive Chairman of the Board and Founder</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">
                          <div style="color: rgb(0, 0, 0);">ACCEPTED AND AGREED:</div>
                        </td>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                          <div style="color: rgb(0, 0, 0);">By:</div>
                        </td>
                        <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                          <div style="color: rgb(0, 0, 0);">/s/ Patrick Schneider</div>
                        </td>
                        <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                        <td style="width: 45%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">
                          <div style="color: rgb(0, 0, 0);">Patrick Schneider</div>
                        </td>
                        <td style="width: 5%; vertical-align: top;">&#160;</td>
                        <td style="width: 45%; vertical-align: top;">&#160;</td>
                      </tr>

                  </table>
                  <div><br>
                  </div>
                </div>
              </div>
            </div>
          </div>
          <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div id="DSPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div>
            <div>
              <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
            <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
            </div>
            <div><img src="logo.jpg"></div>
            <div>
              <div><br>
              </div>
              <div style="text-align: center; color: #212132; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold;">Quantum-Si Reports First Quarter 2022 Financial Results</div>
              <div><br>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif;"><font style="font-weight: bold;">GUILFORD, Conn. -- (BUSINESS WIRE) &#8211; May 09, 2022 </font>-- <u><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Quantum-Si Incorporated</font></u> (Nasdaq: QSI) (&#8220;Quantum-Si,&#8221; &#8220;QSI&#8221; or the &#8220;Company&#8221;), a life sciences company
                commercializing single molecule protein sequencing, today announced financial results for the first quarter ending March 31, 2022.</div>
              <div><br>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Recent Business Highlights</div>
              <table cellspacing="0" cellpadding="0" id="zee5ec158c6f84979bb31cf3fd3d635f1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9679;</td>
                    <td style="width: auto; vertical-align: top;">
                      <div style="font-family: 'Times New Roman', Times, serif;">Announced the appointment of Patrick Schneider as President &amp; Chief Operating Officer.</div>
                    </td>
                  </tr>

              </table>
              <table cellspacing="0" cellpadding="0" id="z4a0f1f1a6bc34b7b961232d4fc842a5d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9679;</td>
                    <td style="width: auto; vertical-align: top;">
                      <div style="font-family: 'Times New Roman', Times, serif;">Made progress on scale-up activities, technology transfers and contract manufacturer collaborations to build operational scale in preparation for launch.</div>
                    </td>
                  </tr>

              </table>
              <table cellspacing="0" cellpadding="0" id="z5a1b2f03a3a3472da6b1737d7d190221" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9679;</td>
                    <td style="width: auto; vertical-align: top;">
                      <div style="font-family: 'Times New Roman', Times, serif;">Successfully completed the technology transfer to our Garnet Valley, Pennsylvania facility for the scale up of semiconductor chip production.</div>
                    </td>
                  </tr>

              </table>
              <table cellspacing="0" cellpadding="0" id="z52e652e22e9b454198b8446ac9a3ae32" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9679;</td>
                    <td style="width: auto; vertical-align: top;">
                      <div style="font-family: 'Times New Roman', Times, serif;">Shared an application note demonstrating the use of Quantum-Si&#8217;s Platinum<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> sequencer to
                        interrogate variants in Beta Amyloid, a protein of key pathological and clinical significance in the progression of Alzheimer&#8217;s disease.</div>
                    </td>
                  </tr>

              </table>
              <table cellspacing="0" cellpadding="0" id="z8e306915e8eb436fa6ed12bec1d427da" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#9679;</td>
                    <td style="width: auto; vertical-align: top;">
                      <div style="font-family: 'Times New Roman', Times, serif;">Held $434.8 million in cash, cash equivalents and marketable securities as of March 31, 2022, providing sufficient runway to make key investments in the business.</div>
                    </td>
                  </tr>

              </table>
              <div><br>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif;">&#8220;We&#8217;re off to a strong start in 2022, and I&#8217;m pleased to announce that Patrick Schneider will become our President &amp; Chief Operating Officer. Patrick, the team and I are focused
                on launching in the second half of this year,&#8221; said Dr. Jonathan Rothberg, interim Chief Executive Officer. &#8220;I continue to be encouraged that the progress like we saw this quarter will enable us to be all systems go for launch.&#8221;</div>
              <div><br>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif;">&#8220;I&#8217;m honored to help lead this impressive company into the future of Next Generation Protein Sequencing,&#8221; said Patrick Schneider, newly-appointed President &amp; Chief Operating
                Officer. &#8220;I envision, in the coming years, Quantum-Si&#8217;s Next Generation Protein Sequencing technology finding its way to the center of the digital proteomics ecosystem with a wide range&#160; of transformative applications and upstream protein
                sample prep approaches and downstream analytics. I&#8217;m eager to start building this ecosystem with our first launch this year.&#8221;</div>
              <div><br>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">First Quarter 2022 Financial Results</div>
              <div style="font-family: 'Times New Roman', Times, serif;">Research and development expenses were $18.8 million in the first quarter of 2022, compared to $8.0 million in the first quarter of 2021. The increase was primarily due to higher
                personnel costs as a result of increased headcount as well as other internal and external product development activities.</div>
              <div><br>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif;">Selling, general and administrative expenses were $8.4 million in the first quarter of 2022, compared to $3.8 million in the first quarter of 2021. The increase was primarily due to
                higher personnel costs associated with the scale up of our organization and costs related to being a public company.</div>
              <div><br>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif;">Operating expenses were $27.1 million in the first quarter of 2022, compared to $11.8 million in the first quarter of 2021, representing an increase of 130%.</div>
              <div><br>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif;">Net loss was $35.2 million in the first quarter of 2022, compared to a net loss of $11.8 million in the first quarter of 2021. Adjusted EBITDA was negative $27.4 million in the first
                quarter of 2022, compared to negative $11.1 million in the first quarter of 2021. Please see the reconciliation of non-GAAP adjusted EBITDA to net loss in the table provided in this press release.</div>
              <div><br>
              </div>
              <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div id="DSPFPageBreak" style="page-break-after:always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div style="font-family: 'Times New Roman', Times, serif;">As of March 31, 2022, cash, cash equivalents and marketable securities were $434.8 million. The Company recorded $11.5 million of unrealized losses in marketable securities for the
                three months ending March 31, 2022.</div>
              <div><br>
              </div>
              <div>
                <div style="color: #222222; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Webcast and Conference Call Information</div>
                <div style="font-family: 'Times New Roman', Times, serif;"><font style="color: #222222;">Quantum-Si will host a conference call to discuss its first quarter 2022 financial results on Monday, May 9, 2022, at 4:30 PM Eastern Time. Individuals
                    interested in listening to the conference call may do so through the live webcast on the Investors section of the Quantum-Si website under </font><u><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">Events &amp; Presentations</font></u><font style="color: #222222;">. </font>Alternatively, individuals can
                  participate in the call by dialing (833) 927-1758 (U.S. domestic callers) or (929) 526-1599 (international callers) and using access code 600467. An archived webcast will be available for replay following the event.</div>
                <div><br>
                </div>
                <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="color: #000000;">About Quantum-</font>Si Incorporated</div>
                <div style="font-family: 'Times New Roman', Times, serif;">Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable
                  single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at <u><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">www.quantum-si.com</font></u>.</div>
                <div><br>
                </div>
                <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Use of Non-GAAP Financial Measures</div>
                <div style="font-family: 'Times New Roman', Times, serif;">In addition to providing financial measurements that have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;),
                  the Company provides additional financial metrics that are not prepared in accordance with U.S. GAAP (&#8220;non-GAAP&#8221;). The non-GAAP financial measure included in this press release is Adjusted EBITDA. The Company presents non-GAAP financial
                  measures to assist readers of its condensed consolidated financial statements in understanding the core operating results that its management uses to evaluate the business and for financial planning purposes. The Company&#8217;s non-GAAP
                  financial measure, Adjusted EBITDA, provides an additional tool for investors to use in comparing its financial performance over multiple periods.</div>
                <div><br>
                </div>
                <div style="font-family: 'Times New Roman', Times, serif;">Adjusted EBITDA is a key performance measure that the Company&#8217;s management uses to assess its operating performance. This non-GAAP measure facilitates internal comparisons of the
                  Company&#8217;s operating performance on a more consistent basis. The Company uses this performance measure for business planning purposes and forecasting. The Company believes that Adjusted EBITDA enhances an investor&#8217;s understanding of the
                  Company&#8217;s financial performance as it is useful in assessing its operating performance from period-to-period by excluding certain items that the Company believes are not representative of its core business.</div>
                <div><br>
                </div>
                <div style="font-family: 'Times New Roman', Times, serif;">Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate this measure in the same manner. Adjusted EBITDA is not prepared
                  in accordance with U.S. GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with U.S. GAAP. When evaluating the Company&#8217;s performance, you should consider Adjusted EBITDA alongside
                  other financial performance measures prepared in accordance with U.S. GAAP, including net loss.</div>
              </div>
              <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div id="DSPFPageBreak" style="page-break-after:always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div>
                <div style="font-family: 'Times New Roman', Times, serif;">The non-GAAP financial measure does not replace the presentation of the Company&#8217;s U.S. GAAP financial results and should only be used as a supplement to, not as a substitute for,
                  the Company&#8217;s financial results presented in accordance with U.S. GAAP. In this press release, the Company has provided a reconciliation of Adjusted EBITDA to net loss, the most directly comparable U.S. GAAP financial measure. A
                  reconciliation of Adjusted EBITDA to corresponding U.S. GAAP measures is not available on a forward-looking basis because the Company is unable to predict with reasonable certainty the non-cash component of employee compensation expense,
                  changes in its working capital needs, the impact of earnings or charges resulting from matters the Company considers not to be reflective, on a recurring basis, of its ongoing operations, and other such items without unreasonable effort.
                  These items are uncertain, depend on several factors, and could be material to the Company&#8217;s results computed in accordance with U.S. GAAP. Management strongly encourages investors to review the Company&#8217;s financial statements and
                  publicly-filed reports in their entirety and not rely on any single financial measure.</div>
                <div><br>
                </div>
                <div style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Forward Looking Statements</div>
                <div style="font-family: 'Times New Roman', Times, serif;">This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995.
                  The actual results of the Company may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate,"
                  "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions (or the negative versions of such words or expressions) are
                  intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations with respect to future performance and development and commercialization of products and
                  services. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the
                  Company's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the impact of COVID-19 on the Company's business; the inability to maintain the listing of the Company's Class A
                  common stock on The Nasdaq Stock Market; the ability to recognize the anticipated benefits of the recently completed business combination, which may be affected by, among other things, competition and the ability of the Company to grow
                  and manage growth profitably and retain its key employees; our ongoing leadership transition; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success, cost and timing of the
                  Company's product development and commercialization activities; the potential attributes and benefits of the Company's products and services; the Company's ability to obtain and maintain regulatory approval for its products, and any
                  related restrictions and limitations of any approved product; the Company's ability to identify, in-license or acquire additional technology; the Company's ability to maintain its existing lease, license, manufacture and supply
                  agreements; the Company's ability to compete with other companies currently marketing or engaged in the development or commercialization of products and services that the Company is developing; the size and growth potential of the markets
                  for the Company's future products and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of the Company's products and services following anticipated commercial launch; the Company's
                  estimates regarding future expenses, future revenue, capital requirements and needs for additional financing; the Company's financial performance; and other risks and uncertainties described under "Risk Factors" in the Company&#8217;s Annual
                  Report for the fiscal year ended December 31, 2021, and in the Company's other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon
                  any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any
                  change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.</div>
                <div><br>
                </div>
              </div>
              <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div id="DSPFPageBreak" style="page-break-after:always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">QUANTUM-SI INCORPORATED</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-style: italic;">(in thousands, except share and per share amounts)</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(Unaudited)</div>
              </div>
              <div>
                <div><br>
                </div>
                <div>
                  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z203f7ce27dd641e3ba20c66e7a7fb05a" class="cfttable">

                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="6">
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Three months ended March 31,</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> 2022</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">2021</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Operating expenses:</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Research and development</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">18,771</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">7,972</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                          <div style="margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Selling, general and administrative</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">8,369</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">3,807</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                          <div style="margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total operating expenses</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">27,140</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">11,779</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Loss from operations</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(27,140</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(11,779</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Dividend income</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">855</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">-</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Change in fair value of warrant liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">2,647</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">-</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Other expense, net</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(11,537</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">-</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Loss before provision for income taxes</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(35,175</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(11,779</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Provision for income taxes</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">-</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">-</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Net loss and comprehensive loss</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(35,175</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(11,779</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                      </tr>
                      <tr>
                        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Net loss per common share attributable to common stockholders, basic and diluted</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(0.25</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(2.13</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">)</div>
                        </td>
                      </tr>
                      <tr>
                        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                          <div style="text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">138,619,929</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">5,528,551</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
              <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div id="DSPFPageBreak" style="page-break-after:always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">QUANTUM-SI INCORPORATED</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CONDENSED CONSOLIDATED BALANCE SHEETS</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-style: italic;">(in thousands, except share and per share amounts)</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(Unaudited)</div>
              </div>
              <div>
                <div><br>
                </div>
                <div>
                  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z50d339bd5eb846edb155be21001e92fc" class="cfttable">

                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">March 31,</div>
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">2022</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">December 31,</div>
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">2021</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Assets</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Current assets:</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="2">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Cash and cash equivalents</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">34,984</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">35,785</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Marketable securities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">399,810</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">435,519</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Prepaid expenses and other current assets</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">4,985</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">5,868</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total current assets</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">439,779</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">477,172</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Property and equipment, net</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">11,151</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">8,908</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Goodwill</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">9,483</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">9,483</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Other assets</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">690</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">690</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Operating lease right-of-use assets</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">15,035</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">6,973</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total assets</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">476,138</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">503,226</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: top; width: 76%;">
                          <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Liabilities and stockholders' equity</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Current liabilities:</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Accounts payable</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">4,293</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">3,393</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Accrued expenses and other current liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">8,779</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">7,276</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Short-term operating lease liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">973</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">859</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total current liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">14,045</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">11,528</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">Long-term liabilities:</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Warrant liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">4,592</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">7,239</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Other long-term liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">240</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">206</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                          <div style="margin-left: 9pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Operating lease liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">15,386</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">7,219</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">34,263</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">26,192</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Stockholders' equity</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Class A Common stock, $0.0001 par value; 600,000,000 shares authorized as of March 31, 2022 and December 31, 2021;
                            118,972,397 and 118,025,410 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">12</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">12</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                          <div style="text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Class B Common stock, $0.0001 par value; 27,000,000 shares authorized as of March 31, 2022 and December 31, 2021;
                            19,937,500 shares issued and outstanding as of March 31, 2022 and December 31, 2021</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">2</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">2</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Additional paid-in capital</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">744,268</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">744,252</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                          <div style="text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Accumulated deficit</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(302,407</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(267,232</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">)</div>
                        </td>
                      </tr>
                      <tr>
                        <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                          <div style="text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total stockholders' equity</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">441,875</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">477,034</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Total liabilities and stockholders' equity</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">476,138</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">503,226</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
              <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div id="DSPFPageBreak" style="page-break-after:always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">QUANTUM-SI INCORPORATED</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">RECONCILIATION OF U.S. GAAP TO NON-GAAP FINANCIAL MEASURES</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-style: italic;">(in thousands)</div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif;">(Unaudited)</div>
                <div><br>
                </div>
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Adjusted EBITDA</div>
              </div>
              <div>
                <div><br>
                </div>
                <div>
                  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zf0e481c0edf74e9195f5d32de0caecfe" class="cfttable">

                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="6">
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Three months ended March 31,</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> 2022</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
                          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">2021</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Net loss</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(35,175</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(11,779</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%;">
                          <div style="text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Dividend income</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(855</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">-</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Change in fair value of warrant liabilities</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(2,647</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">-</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: top; width: 76%;">
                          <div style="text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Other expense, net</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">11,537</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">-</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                          <div style="text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Stock-based compensation</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">(714</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">457</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                          <div style="text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman', Times, serif;">Depreciation</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">452</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif;">213</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
                      </tr>
                      <tr>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                          <div style="text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Adjusted EBITDA</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(27,402</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">$</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(11,109</div>
                        </td>
                        <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">)</div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div><br>
                </div>
                <div><br>
                </div>
                <div style="color: #212132; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Investor Contacts</div>
                <div style="color: #212132; font-family: 'Times New Roman', Times, serif;">Juan Avendano</div>
                <div style="color: #212132; font-family: 'Times New Roman', Times, serif;">Mike Cavanaugh</div>
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"><u>ir@quantum-si.com</u></div>
                <div><br>
                </div>
                <div style="color: #212132; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Media Contact</div>
                <div style="color: #212132; font-family: 'Times New Roman', Times, serif;">Jon Yu</div>
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255); font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"><u>QSI-PR@westwicke.com</u></div>
                <div><br>
                </div>
                <div style="font-family: 'Times New Roman', Times, serif;">Source: Quantum-Si Incorporated</div>
                <div style="font-family: 'Times New Roman', Times, serif;"> <br>
                </div>
                <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                  <div id="DSPFPageBreak" style="page-break-after: always;">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div>
                  <div>
                    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
                    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.2</font><br>
                      <br>
                    </div>
                    <div>
                      <div><img width="178" height="44" src="image0.jpg">
                        <div><br>
                        </div>
                      </div>
                      <div style="text-align: center; color: rgb(33, 33, 50); font-weight: bold;">Quantum-Si Appoints Patrick Schneider as President and Chief Operating Officer</div>
                      <div>
                        <div><a name="z_headingh.1fob9te"></a><br>
                        </div>
                        <div><a name="z_headingh.3goh2t41wn0p"></a><font style="font-weight: bold; color: rgb(33, 33, 50);">GUILFORD, Conn.&#8212;(BUSINESS WIRE)--May 09, 2022</font><font style="font-weight: bold; color: rgb(0, 0, 0);">--</font><font style="color: rgb(0, 0, 0);">&#160;</font><u>Quantum-Si Incorporated</u><font style="color: rgb(0, 0, 255);">&#160;</font><font style="color: rgb(33, 33, 50);">(Nasdaq: QSI) (&#8220;Quantum-Si,&#8221; &#8220;QSI&#8221; or the &#8220;Company&#8221;), a life sciences company
                            commercializing single molecule protein sequencing, today announced the appointment of Patrick Schneider, Ph.D.,</font><font style="color: rgb(0, 0, 0);"> as </font>President and Chief Operating Officer (COO)<font style="color: rgb(0, 0, 0);">. Schneider will succeed Michael McKenna, Ph.D., who will remain as Executive Vice President, Product Development and Operations.</font></div>
                        <div><br>
                        </div>
                        <div><a name="z_headingh.aw4qj099i0ot"></a>&#8220;We have made substantial progress towards launching the world&#8217;s first true next generation protein sequencing system and I am thrilled to work with Patrick to raise the probability of our
                          near-term and long-term success,&#8221; said Jonathan Rothberg, Ph.D., Interim Chief Executive Officer, Founder and Executive Chairman of Quantum-Si. &#8220;Patrick brings more than two decades of life science senior leadership experience and
                          I am excited to be able to pass the day-to-day leadership of this gifted team to him as we execute our ambitious plans to transform the proteomics landscape.&#8221;</div>
                        <div><a name="z_headingh.bn9e6lrwzog5"></a><br>
                        </div>
                        <div><font style="color: rgb(0, 0, 0);">Schneider brings over 25 years of experience as an accomplished life science leader and entrepreneur. Schneider joins Quantum-Si from MilliporeSigma, where he most recently served as Senior
                            Vice President of Strategy, Business Development and Innovation, and Chair of the Life Science Innovation Board. During his 16</font>-<font style="color: rgb(0, 0, 0);">year tenure with MilliporeSigma and its predecessor
                            entities, Schneider held roles of increasing responsibility and led strategy development for </font>the<font style="color: rgb(0, 0, 0);"> Research Solutions Business Unit, executed over 250 technology access, co-development
                            and distribution agreements, developed in- and out-licensing strategies, and oversaw a global team of over 300 biologists, chemists and engineers. Earlier in his career, Schneider served as Vice President of R&amp;D, Business
                            Development and Scientific Affairs at Serologicals, Inc., where he developed and implemented the company&#8217;s M&amp;A and partnership strategy. He also served as Chief Scientific Officer at Chemicon International, where he founded
                            the Beckman Institute for Biomedical Research and co-founded Genome Biosciences, Inc., and Integrated Cell Technologies, Inc.</font></div>
                        <div><br>
                        </div>
                        <div style="color: rgb(0, 0, 0);">&#8220;I&#8217;m honored to help lead this impressive company into the future of next generation protein sequencing,&#8221; said Dr. Schneider. &#8220;I am excited about the Quantum-Si technology &#8211; to bring the power and
                          scalability of semiconductor chip technology to this field and help answer questions in proteomics that might be too difficult or expensive to answer using historical approaches. Together with the rest of the leadership team, I&#8217;m
                          eager to start building this ecosystem with our first launch this year.&#8221;</div>
                        <div><br>
                        </div>
                        <div style="color: rgb(0, 0, 0);">Schneider holds a B.S. in microbiology from Northern Arizona University and earned a Ph.D. in biology from the University of California, Irvine, where he conducted virology research for neurotropic
                          RNA viruses.</div>
                        <div><br>
                        </div>
                      </div>
                      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                        <div id="DSPFPageBreak" style="page-break-after:always;">
                          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
                      </div>
                      <div>
                        <div style="font-weight: bold;"><font style="color: rgb(0, 0, 0);">About Quantum-</font>Si Incorporated</div>
                        <div>Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein
                          sequencing and digitize proteomic research in order <font style="color: rgb(0, 0, 0);">to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at </font><u>www.quantum-si.com</u><font style="color: rgb(0, 0, 0);">.</font></div>
                        <div><br>
                        </div>
                        <div style="font-weight: bold;">Forward Looking Statements</div>
                      </div>
                      <div>
                        <div>This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. The actual results of the Company may differ
                          from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast,"
                          "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions (or the negative versions of such words or expressions) are intended to identify such
                          forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations with respect to future performance and development and commercialization of products and services. These
                          forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the
                          Company's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the impact of COVID-19 on the Company's business; the inability to maintain the listing of the Company's
                          Class A common stock on The Nasdaq Stock Market; the ability to recognize the anticipated benefits of the recently completed business combination, which may be affected by, among other things, competition and the ability of the
                          Company to grow and manage growth profitably and retain its key employees; our ongoing leadership transition; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success,
                          cost and timing of the Company's product development and commercialization activities; the potential attributes and benefits of the Company's products and services; the Company's ability to obtain and maintain regulatory approval
                          for its products, and any related restrictions and limitations of any approved product; the Company's ability to identify, in-license or acquire additional technology; the Company's ability to maintain its existing lease, license,
                          manufacture and supply agreements; the Company's ability to compete with other companies currently marketing or engaged in the development or commercialization of products and services that the Company is developing; the size and
                          growth potential of the markets for the Company's future products and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of the Company's products and services following
                          anticipated commercial launch; the Company's estimates regarding future expenses, future revenue, capital requirements and needs for additional financing; the Company's financial performance; and other risks and uncertainties
                          described under "Risk Factors" in the Company&#8217;s Annual Report for the fiscal year ended December 31, 2021, and in the Company's other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive.
                          The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any
                          updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.</div>
                        <div><br>
                        </div>
                        <div style="color: rgb(33, 33, 50); font-weight: bold;">Investor Contacts</div>
                        <div style="color: rgb(33, 33, 50);">Juan Avendano</div>
                        <div style="color: rgb(0, 0, 0);">Mike Cavanaugh</div>
                        <div style="color: rgb(0, 0, 0);"><u>ir@quantum-si.com</u></div>
                        <div><br>
                        </div>
                        <div style="color: rgb(0, 0, 0); font-weight: bold;">Media Contact</div>
                        <div style="color: rgb(0, 0, 0);">Karen Chase</div>
                        <div style="color: rgb(0, 0, 0);"><u>QSI-PR@westwicke.com</u></div>
                        <div><br>
                        </div>
                        <div><br>
                        </div>
                        <div>
                          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
                      </div>
                    </div>
                  </div>
                </div>
                <div style="font-family: 'Times New Roman', Times, serif;"> <br>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ] /4# 2(  A$! Q$!_\0
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M%+FZBBF=T_<ZA9R#?CH,.,AA['(KYW\;?!GQ'X3,UU;1'5-+3+?:+=?G1?\
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MLVJQ7UQ'J#2&4W*2%9"Y.2VX<Y))H ]6T+P7\7KKQ/%)<76JV9$@::ZN+\[
M,\]&.[TP ?RKLOB7_P ES\!_[\?_ *-->)W_ ,1O&.J61L[OQ'?O;LNUD639
MN'HQ7!/7OUJA?>+/$&I:G:ZE>ZO=SWMK_J)WD^>/G/RGMS0!V?QY_P"2J7G_
M %[P_P#H KK/@O\ \DL\<?\ 7*3_ -$-7B>IZKJ&M7K7NIWDUW<L IEF<LQ
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MY888Q@A<9'L: /1]2U'3=3_:?L)],>.2-;B*.66,Y5Y%CPQ!]N!^%><?$?\
MY*5XC_["$W_H1K L-0N]+OHKZQG>"ZA.Z.5#AE/3(IM[>W.HWLUY>3--<S,7
MDD?J['J3[T 04444 %%%% #HY9(95EB=DD4Y5E."#Z@UZYX*^/6N:&4M/$ ?
M5[$# D)Q<)_P(_>_X%S[UY#10!Z%XX^+_B#QDS6ZE-.TX,2EO!]\CI\TG4\9
MZ8'/2O/:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +S!5$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!"<57NI0L+'-%U+Y:9KF=5U<1Q,-U:4X.3);LCF/%NJF-6 :O/I
M;TS@DFM3Q'??:2P!S7-Q9 KWJ--1@<$Y-R) ,M3NAQ0.*0]:V%U',.*%Z4IY
M%-S@8I V Y-)CFA>M!ZTPZCCP*,9%(QXI0?EIBL(O6@]<4@/-!/S4NHP<<58
M@N#",YZ5">14;_=H:N(['P_K!\T#=WKUS1;D2VH.:^?-)G,,P.>]>K^']8 M
MU7=7G8RC?5'52D>A!@:6LRQNQ-CG-:=>2U9G0G<****0PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "FLX44ZL^_G\N)CGI515V)LHZU>JD1PU>8:[JC;F
M:MG7M9^\NZN!U"Z\YSS7JX:C9:G/4GT*$D[32G/K3=N#357#9J7&>:]!'*@/
M2F4_K32.::&A5IK]:=TI<9&:%N)ZC*,\T=Z3^*F4+12D8% '% "44H'-!ZT
M*M-<4_I01D9I"ZD:L8VR*Z;1]29-HS7,D9-6[67RF'-*45)%)V9['X=U ,1E
MJ[&.4..#7C6BZMY3+\U>E:/?>?$IS7BXBBT[G53E='044BG(I:XC8**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY6>WVUVLBC!J\IR*XK1-1\T+EJZ^WD#(*\2I#E9V1=R>BBBL2@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444A-
M"TF:A>3%1_:.>M %K-+507'O4B2YH GHI >*6@ HHHH **** "BBB@ HHHH
M**** /&-:U9E@.&KBKB\:=B2:O:E=>;'C-9"+7T=&FHH\^4KL .<TXTX+2,.
M:V$-S2T8Q3@.*!+82DIP'--/6FQCE-,*,S\"D8[:Z'1M,-VJMC-1.7*KB2N[
M%OPK8&6<;E[UZKIVEJD8.*P?#VC?9W!VUW=O&%3&*\?%5N:6AUTH60D$ CZ5
M8HHKA;N;A1112 **** &2)N%9-WI:RDD@5LTA (JHR:$U<\L\7:4(H256O,I
MXF27&*][\1V'VF$C':O+-9TDP,S;>E>OA*UU9G-5AV.6<X%-!XH?[Y7TH%>@
MT<T=QZ\T-0!B@C-2A]1H-/\ X::!FG>U-@R$C)JQ#<&+I41&*:5XIVN">AO6
M.K,LBC)ZU[/X5G,VG*Q]*^?(&*S+]:]Z\$'.DI]*\W,(I1NCHH,ZFBBBO(.H
M**** "BBB@ HHHH **** ()YUB7DXKB/%VK+%82%6[>M6_&.L#3H_O8KQ[Q)
MXH^T6LB;^OO0!S&I^)Y!<. YZ^M8T_B*212"QK$O)C),QSU-5.<4 :_]JOG.
M32?VJ^>IK(&:.<T ;!U9SW-30:V\; [C6#S2\T =C!XHE\Q1N/7UKU[P;KGF
MQQ[F_6OG.-B) ?>O0?#FN_9%0;L8H ^H;*^1XU^8=*TT8,,BO&]$\5B4HN_]
M:]4TBY%Q:*^>M &E1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 449HS0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !113)6VQL?:@"-[E4."14#
MWL8'WA7%ZWX@%M<LN[&*Y^?Q: #\_P"M 'HEQJ,8S\PJC_:B9^\*\ONO&(W$
M>9^M4O\ A+AG[_ZT >O+JB9^\*N0:BA_B'YUXL/%XS]_]:N6_C 9'[S]: /;
MX[V,K]X5/'.K]#7DEOXM!0?/^M=7X>UH7G\6:!7.V'-%1PMN3-24#"BBB@ H
MHHH **,T4 %%%% 'R\\A8=:5!Q4=/4U]0M#S;:$@IC_>IQ.!49.30@6PX]*!
MTH!S36.#BD(5>M(WWJ0'%* 6-4,>MNTQ 45Z=X.TS_1UW+7)^&M/^UW !&>:
M]<T;3A:Q*-N*\_&5K+E-J,-;FG:VB1H"!5T# H487%+7CMW.P****0!1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@!KMM7-9ESJD<).6J[>OLMG;T%>1>*O$1M&?Y\8H ]$_X2
M"'^^/SIRZ]"Q^\/SKP ^-6S_ *S]:LVGC)GD \SOZT ?1EI<K<)N4U9KD?!-
M^;VP#DYXKKJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)_=-)]BD_NG\J ( >:1C5G[')_=-!LY/[IH J[CBGI*R]#4AM7'8U$8RO44
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M<5SXB5H&E):G>Z;!Y<*\=JTZB@3;$*EKP9.[.U!1114C"BBB@ HHHH ****
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M G7(-6Z "BBB@ HHHH IZG_QXR?2OFWXCGF7ZFOI+5/^/&3Z5\U_$;[TOU-
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MVK="@4 .HHHH *0C(I:* ,B^LQ*#Q7!>)/#8GC8[.WI7J10&L^_M%D@;@=*
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MV7=C% '8?:4]12K.K' ->;-XK4'[_P"M7=*\2"XN@F_.?>@#T$'-+5>VD\Q
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M45Y]<>)PDF-_ZU WBI0/O_K0!Z4LRMT-2UQ6D:X+DK\V<UV,+;H@: )****
M"BBB@ IC2!>II6.%KG=<U,6D9.[% &[]I3U%'VE/45YT?%*Y^_\ K3#XK7</
MG_6@#TU'##(IU8^@WOVRT#@YK8H 0G S4/VE,XR*BU*;R+1WSC KS^7Q2JW#
M+OZ'UH ]%^TIZBGI*K]#7FK>*E'\?ZUN^'=:%])@-F@#KFD"]36%K=\L4?6H
M]6U06V?FQBO/-?\ $P(8;_UH T;O6MKGYJJIKGS?>KSV[U_+GYZK)KWS#YZ
M/>=%U(2(N6KJX9U=1@UX5HOB4)&OSUZ'X>UT7C ;LT =S14<+;DS4E "$@"H
M9+A0IYJ"_G\F!FSTKB+_ ,2",N-_3WH L:YJHCE8!JYT:Y\Q^:N4U[Q('G;Y
M_P!:YX:]R?GH8,]0M=;W7(&ZN[TB^61!\W:OGBUU_%P#OKOM#\4 !1O_ %H
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M/6]X/UAYM712W>O,9+L[CS74> [@MKD8SWH ^K-*??;H?:M*LC13FU3Z5KT
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M>$];W2QAGKV.PO$FA7![5\I^'M<,-PGS=Z]V\'ZS]K11NSQ0!Z(#FEJ.%MR
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MKO\ ^SHO[@H8'BW_  A'_3/]*W?#OA7['<!MF.?2O3/[.B_N"I([*.,Y"BD
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M-5NU(&>@?#R[QK,*9[BOK#3SFQB/^R*^-_ DQC\0P\_Q"OKS1;D2V,(']T4
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MIKY9^(Q_XFDWU- 'F9^\:ZWX?_\ (?C^M<D?O&NM^'__ "'X_K0+J?6FA_\
M'K'_ +M;-8VA_P#'K'_NULT#"BBB@ HHHH Y[Q)_QXS?[IKY&\8_\A^;_>KZ
MY\2?\>,W^Z:^1O&/_(?F_P!Z@#GW-=C\.#_Q/H_K7'-S79?#@?\ $^C^M 'U
MEHQS;)]*UJRM'&+9/I6K0!6O4WVSKZBO+W\/B76F?9U/I7JTHS&1[5AQ68^V
MEL=Z )M$T\6<0 &.*V::BA5&*'.!0 N:,U4:?!ZTW[0/6@"[FJ6I6XN+<KC/
M%.6?)ZU9^\E 'S=\3=+\FY8A>]>.7 V2D5]*_$S3?.+L%KYRU6+RKUU]#0!5
M0X8'TKU3X479;643/<5Y4!@5Z-\)"?\ A($^HH$?6,7^J7Z4YONGZ4R'_4I]
M*>WW3]*!GS+\;?\ D*?C7CZFO8/C;_R%/QKQ]10!(O,@'O7>>#M+^TW297/-
M<-;+OND7U->Y^ -&P8I"OI0!Z7X7T@6\"_+CBNSC7:@%4M-@$40&.U:% !11
M10!#=1^9;LOJ*\*^*6C"&TDE"]<U[T1D5Y?\6;<-H[<=J /E<\.WUI#U%3W<
M?ES,/>JYIDO<]9^'%YY;1+GN*^E=*;=81GVKY2\"3[+N$9[BOJC0SNTN$_[-
M-[%$VI_\>,GTKYK^(P^:7ZU]*:G_ ,>,GTKYL^(WWI?K20T>2CO6CHW_ !]#
MZUG>M:&C\7(^M(3/J;X7_P#(*7Z5Z'7G?PN_Y!2_2O1*!(****!A7FOQ5.-+
M/TKTJO-?BJ,Z6?I0!\NZJ?\ 26^M9^>16AJHQ<GZUGXY%- >G_#\_P"DP_45
M]0:3_P @^+Z5\O\ P_'^DP_45]0:3_R#XO\ =I 7:*** "BBB@""Z_U+?2O#
M/BN<VK5[G=?ZEOI7AOQ7&+5J / I?]8?K0G^M3ZTDO\ K#]:$_UJ?6@#ZN^$
M7_(OI]!7I->;?"+_ )%]/H*])H YSQK_ ,B]<?[IKXWUG_D+3_[QK[(\:_\
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M#S8_>-=9\/\ _D/1_6N4_B-=9\/_ /D/Q_6@#ZTT+_CUC_W:V:QM"_X]8_\
M=K9H **** "BBB@#GO$G_'E+_NFOD7QC_P A^;_>KZZ\2?\ 'C-_NFOD7QE_
MR'YO]Z@#"[5V7PW_ .0_']:XSM79?#@_\3^/ZT"1]::3_P >R?2M.LK1SFV3
MZ5JT#$/(J$0@/FIZ3(H C>54ZFJ=U?(D>=PK,UO4!;-UKBM9\2>5 3O_ %H
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L7Q-_R!Y?I6U6+XG_Y
M\OTJZ?QH4MCYXN_^/^7_ 'C3:=<<ZA+_ +QI.]?2K8\Y"K0U*>!1VH0%=_\
M6K]:]Z\!?\@=/I7@Y'[Y?K7O/@/_ ) Z?2N+,/X:-J#]XZVBBBO$.P**** "
MBBB@#POXX_ZBOGKM7T)\<O\ 45\\@\TT Z+_ %Z?6OH?X:M_HT/X5\]1C]\G
MUKZ!^&I_<0_A2 ]R@_U*_2I*C@_U*_2I* "BBB@ HHHH **** "BBB@ K'\0
M_P#(/?Z5L5C>(SC3G^E ,^8OB+_KV^M>=_PUZ%\0VS.WUKSS^&@2V+FEINOH
MO]X5]@_#T8\.P_[HKY(T*+?>Q?[PKZ[\!KMT"$>U SHKW_CSE_W37RS\1O\
MD*S?4U]37O\ QYR_[IKY8^(W_(5F^IH$SS4?>-=9\/\ _D/Q_6N3_B-=9\/_
M /D/1_6@9]::'_QZQ_[M;-8VA?\ 'K'_ +M;- !1110 4444 <]XD_X\9O\
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M_K$^M+-S(:1/]:GUH!'U=\(O^1?3Z"O2:\V^$7_(OI]!7I- '.>-?^1>N/\
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MS,>:C+$T[%-QDT  -+GF@(?2E\MO2@!&--#'-/*'TINPB@!PD:C)I *4]*
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M\A2'_>%?67@<_P#$L@_W17R;I'_(4A_WA7UAX&_Y!D'^Z*8+8[P=*6D'2EI
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M!-,>!7'(H \&\0^$M\SR;/TKRSQ-IGV%L;<5]9ZKI4<D+'8*\#^).D%7)5:
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M_P"0?%_NT@+M%%% !1110!!=?ZEJ\.^*IS:M7N-U_J&KP[XJC%LU#!G@,_\
MK#]:1/\ 6I]:6?\ UI^M(G^M3ZT ?5WPB_Y%]/H*])KS;X1?\B^GT%>DT <Y
MXU_Y%ZX_W37QMK1_XFT_^\:^R?&O_(O7'^Z:^-=:'_$VG_WC0@*?5:]D^"0_
MXF'XUXW_  U['\$C_P 3#\: /I1/NCZ4ZFI]T4Z@ HHHH *\0^.'_'G^%>WU
MXA\</^//\* /G0=Z<O\ K5^M(.]*O^M7ZTR5N>[?#7_5P_A7OEK_ ,>Z?2O
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M2@#P"7[YIJ?ZU/K3I?OGZTB#]ZGUH ^KOA%_R+Z?05Z37FWPB_Y%]/H*])H
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M*0_[PKZQ\#'_ (ED'^Z*81V.['2EI!TI:0!1110 5R?C;_D'M]*ZRN3\;?\
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M"?ZU/K2/]XT)_K4^M 'U=\(O^1?3Z"O2:\V^$7_(OI]!7I- '.>-?^1>N/\
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M/^/63_=-?,OQ&MS]NF;'>@#R;^(U8L7\NX!]ZA/WV^M)&VV3- 'T5\+-2Q&
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MSX#_ .0.GTKP<_ZY?K7O/@3_ ) Z?2N+,/X2-J'Q'6T445XAV!1110 4444
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MHY_]2_TH ^>_B5_KYOQKQ"3_ %S?6O;_ (E?Z^;\:\/E_P!>_P!: -/P^?\
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MMO\ B2PMCL*]#7[HKD/ $&SP_#D?PBNPH :YPM>#?&'YG->[R_<KPCXN_?-
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M,#T_1?$9B"C?78P>*SY8^?\ 6O#K2[9,<FMN+4V"CYC^=2A(]3NO%9\H_/\
MK7">(-?-P&&ZL6XU-BA^8U@75RTC'DTQD=W)YKDYJL.M.)XYJ,=: >Q+2H/W
MJ?6FBGI_K4^M D?5OPB_Y%]/H*])KS;X1?\ (OI]!7I- SG/&O\ R+UQ_NFO
MC?6?^0M/_O&OLCQK_P B]<?[IKXWUG_D+3_[QH I'I7L'P4'^G_C7CYZ5[#\
M%/\ C_\ QH!'TI']P?2GTR/[@I] ,**** "O$/CA_P >?X5[?7B'QP_X\_PH
M ^=1W-"']ZOUH[&D3_6K]:8'O'PU_P!7#^%>^6O_ ![I]*\#^&O^KA_"O?+7
M_CW3Z4@)J*** "HY_P#4M]*DJ.?_ %+?2@#Y[^)7^OF_&O#Y?]<_UKW#XE?Z
M^;\:\/E_US_6@3-/P\/^)I']:^H?  Q"GTKY>\/?\A6/ZU]1> ?]2GTI@>AU
MS_B+_CV?Z5T%8NN1&2!A[5+!GREX[C)U:0^YKB@,/7K/CG16^U2R;3UKRV>+
MRI"/>F'0VM$U$VTRG.,5ZEHWBHX0;_UKP^.4JW!K?TS4&1U^8T#/I;1-:\\+
M\U=6+L; <UX7X=UX1A,O^M=N/$Z;!\XZ4 =Y]L'K3TN@>]>?_P#"3)_?%21^
M)T ^^/SH [LW8SUK,U341%&3N[5RI\3IN^^/SK'UKQ&KQ-AQT]: */B3Q.4W
MKO\ UKR+Q#J)O9"<YYJ]XAU-I9GPU<D\I=CDT ,KL?!NG?:;F,[>C5REK"9Y
M@HKV'X>Z*596*]Z /=/"</D:1&N.@K?K/TB+RK-5]JT* &2#*UX/\8?E<U[T
MW2O!OC(/GH \"G/[XUZY\+SF*O(I_P#7&O7?A=_JJ /4Z*** /)VI5'&:86S
M3U/%?4(\U;"#KB@]:!P<TA/-,.HK=*0#C-!/% /% ="6WF,;UT>E:L4E5=U<
MKT.:LVLI253FLZD5)%*5CW#0;X2*N373JX8<5Y#HFM"+:-U>B:3J N8P<UXN
M(HN+N=<)W1NT4BG*TM<AJ%%%% !1110 4444 %%%% !32P%.[5EZA=^2K'/2
MJC&[L S5;H1QGFO+M?U8B9E#5N:SKH(9=U>>:K<F:8MFO4PE&SU.6K/0KW5V
M92>:JXR,U'G)J13Q7IV2.?H"T=Z4<4WO2 5J4#Y:.HHS@4("(\S+]:]X\"?\
M@=/I7@I.)5^M>]> SG1T^E<68?PD;4/C.MHHHKQ#L"BBB@ HHHH **** $89
M4BN*\1Z$MPCOMKMJJ7T(D@88H ^5O'>D&V9MJXYKSID*G!%?2/C7PZ;H,0F?
MPKQ36='-I*PVXQ0!S&*7'%.E7:U,SQ0(<K8-3K<D+C-5J0T#1.\Y;O41YI@I
MV>* % I",T U=L[?SI ,4 %C:M(XXKIIM,*Z;NV]JV?#OALSE3L_2NSO/#17
M3"NSMZ4,3/!98RLC CO4==-K]I-IC3I'(\:3+LE56(#KN#8/J,JIP>X![5S/
M:F!JZ/>&WN8\''-?3/@/41+I\0+=A7RI ^V=3Z&O;? 6NA%BBW>E2P9]#1L&
M456U"#S[<J15;2;O[1$ISVK489%,9\\?$W2/*=B%KQ2ZA,<IXKZI\>Z/]M5B
M%SQ7@/B+13;2.=N,4 <<.:4<&AOE8BFDT 6$N"HZTIN3ZU4HH"Y;%Y,B2I'*
MZ),FR558@.N0V#ZC*J<'N >U52,T=*<@W-B@&"1,W04FTJ>:[#0="-[;,^W.
M!7/ZM:FUNW3&,&@"CVKLOAO_ ,A^/ZUQ>:[/X;G_ (G\?UH ^M-(&+9/I5VX
MC\R,BJ.CG-LGTK4/2@#POXG:;ND8A:\%U"!HKAACO7U=XUTK[8&.W/%> ^*=
M#-LTC[<4"ZG""GJVTYIAX8BDSF@99^TGUI?M1QUJF:* +7VDXQFH'.XYJ+-2
M+S0 HC+#(I-I!KI-)TDW5N7VYXK.U"S-O(PQTH SNU>A_"3_ )&%/J*\Z)KT
M7X2?\C GU% 'UC#_ *E/I3V^Z?I3(?\ 4I]*>WW3]* /F7XV_P#(4_&O(0.*
M]>^-O_(4_&O(,\4 7=(_Y"D/^\*^L? Q_P")9!_NBODW1_\ D*0_[PKZQ\#?
M\@V#_=% ([P=*6D'2EH **** "N3\;?\@]OI765R7C?_ )![?2@#Y:\9_P#'
M\?K7+^E=/XS_ ./UOK7+9H$=IX,_Y"$/^\*^M/#_ /R"(?\ =KY)\&G_ (F,
M'^\*^M?#_P#R"(?]V@#5I#TI:*!G%>+]&6ZM)9-N>*^8O$M@8+V4 =#7V)JD
M(FL9%QU%?/WC'PX?.E?9U/I0!XH5(/-**T]3LS;RD8[UEYP:!#P^VNP\$S'[
M<OUKBF-==X'YOU^M SZG\'MFQ7Z5T]<MX-_X\%^E=30!S?B6Q$UA*<=J^9/&
M.G&*YE(7O7UGJ47FV;KCJ*\0\8^'C(9&V?I0!X"RE6YI:U-:LC:7!7&.:RLT
M /5]M2BY([U6/2FC- %MKDD=:@)W&HS2@T +M).!2F)@,XK4M-.<W21ML8LJ
MO\CJXPP##D$C.#R.H.0<$$5NZEH!@M%?9VH X\# I4_UR?6GW">6Y%11G]\G
MUH ^L/A%_P B^GT%>DUYM\(O^1?3Z"O2: .<\:_\B]<?[IKXWUC_ )"T_P#O
M&OLCQK_R+UQ_NFOC;63C5I_]XT 4FZ5[#\$_^/\ _&O'&->R?!(?Z?\ C0"W
M/I2/[@^E/IJ?='TIU V%%%% @KQ#XX?\>?X5[?7B'QP_X\_PH ^=1U-*O^M7
MZTS/)IR']ZOUH!'N_P -?]7#^%>^6O\ Q[I]*\!^&Q^2'\*]^M?^/=/I0!-1
M110 5'/_ *E_I4E1S_ZE_I0!\]_$K_7S?C7A\O\ KW^M>W?$H_Z1-^->(3?Z
MYOK0)FGX>_Y"D?UKZ@^'Y_<I]*^7O#W_ "$X_K7U!\/O]2GTH&>CU6NH?-0C
M%6:0CB@#RSQMH0:RED"]J^=-9L6CN'P.]?8'B*R%S8.N,Y%>(:WX29WD;R^Y
M[4 >)%"IYJ:*8QD<UKZUIIM+AEQC%8#<&@#HK/6FAQAJU/\ A)WQ]\UQ(8T[
M>WK0!V@\3O\ WS3O^$H<?QFN+WMZT>8Q[TA'9?\ "3OG[YJM<^(7E4C>:Y7>
MWK32[>M,9<N[HS.3FJ@4D\4U<DUM:78&Y8#&>: +'AFQ:?44!'>OI#P;HHAA
M0[>U><^$/"Y%Q'+L_2O==#M!!"HQVH UX$\N,"I:** $;I7A/QB'S&O=FZ5X
M-\8VPYH \#G_ ->?K7KGPP_U5>13']]7KGPQ/[J@#U*BFYHH \D%/!HD0J*1
M.17U-SS5HB0]*93^M-(YI($)2CK2D<4 <4QW!NE .T9I>O%-;TI6))K:^>.0
M<]Z]2\):EN@7<U>1[<-FNIT#4S RKNK#$TU*&AI"5CW2VF$B#!JS7,Z#?>>J
M\UTH((KP:D>5V.V+NA:***@H**** "BBB@ HHHH 9(X537%^)-0$<;@&NHU&
M;RHB<]J\F\4:I^^=-U=F$I\TC.I*R.8U+47>9AGO6<9"XR:;*?,D)I%&.*]M
M)+8X6[C0.:>.M!&*4#C-4P6PK=*93^M-QS20(5:1J=TIK=,T=0('/[U?K7O7
M@'_D#)]*\$P3,OUKWSP&,:.GTKBS#^&C>A\1UU%%%>(=84444 %%%% !1110
M 4UUW+BG44 8VHZ7'/$^5[5X5XVT3;<R;4KZ,D&4(]J\_P#$FA"Y=VV]: /E
MZ_TZ1'/R]ZS7MV0<BO8==\->62=GZ5Q.J:3Y,+';0!Q_>@]*612)",=Z:0<4
M"0BT]5+' I@4YZ5IZ=;&68#%,.I72T<D<5U&@:2[SJ2M:-GH>\K\O6O1_#GA
M<;$?9^E(9N^"]#3RUW+V]*['4-(C^R%0O:I-"L!:H!C%;%RF^(B@#YD^)>E^
M3(2J]Z\ID4IP:^COB3I/FJQVU\^:M"8;IEQT--B110X.:ZWPGJC0Z@@W< UR
M J]I<Y@NE;WI!U/K?P=J(G@7YNU=LIW"O$/AUK'F*H+5[19R>9 #0,JZE8I<
MPMD9XKQ'QUHNT2E5KW^090BN"\4Z.+B)SMZT ?*MW82)*WR]ZSY$*]:]7UGP
M[Y9<[/TKSS5+0PRL,4 9 IPI-I!Z48-,74=MR>*O65B\L@PM1VD)DD48[UZ-
MX8\/_:'3*=:0SK/ .A@Z5(73^$UYGXST]H]9F"KQFOI#P[HXLM-==N,K7E/B
MW1O-U25MO4T >._8W]*[#X>6SIKB$CO5Y=!SGY:Z#P;I'DZPIV]Z /?=&R+9
M/I6M6?IJ;(%'M6A0!GZA9K/&V1VKQSX@Z*!:2%5KW%QE2*XOQ9I0NK5QMSF@
M3/DFYL)(Y&RO>J10JV#7JNN>'/)+G9^E>>ZC:F&5AB@9E-UI3]VD8'/2C!QT
MI@"(6/%7K:QDD886G:?;&1U&.]>A:%X?\[8=GZ4@-/P?HN[3'++_  UR?B?3
MBEQ( O>O=- T,6VG,-O\-<)XCT??=2?+WH \7:S?/2O1/A/;,FO(2.]0/H//
MW?TKL?A[I7V?5U;;WH ^@(?]2OTIS?=/TIL?$:_2G'H: /FOXT0-)J? [UY'
M]C?'2O?OBAI_VG4,XSS7G_\ 8/R9VT <=H]FXU.'C^(5]5^"8RNFPY]!7ANF
M:'MOXSM[U]!^%[?RK"(8[4#1TXZ4M Z44""BBB@ KD_&JEM/;'I765SWBB+S
M;,CVH ^5O%]J[7C<=ZY<6;Y^[7KGB+1O,N6.WO6"N@\_=H H^$+5UU"'(_B%
M?5V@#&DPC_9%>!^'=&\J]B.WH:^@=(79IT0]J +]%%% #)%WH5/>N'\6:.DE
MNQ"\D5W=9FK6PN(2,4 ?+'BK1W2X8A>]<4]DX<C;7T;XD\,B17?9^E>8RZ!B
MY<;.AH$><R0,G45U7@8?Z>OUJ+6-,,#D;:M^#(RNHCCO0-GT_P"#_P#CQ7Z5
MT]<QX/\ ^/%?I73T -D7>A%<KX@TE)86.WM7653OH?-B(Q0!\J^.='=+YMJ<
M9K@IK9XR<BOI/Q;X:%PSR;/TKQK7](^SL_R]* .+(P*:O6IIXRK8Q4 !]* !
MNM30PM(V *B"DMTKH] T\W,P&.],#8\*:0\EW$2O&:]'\4:,L>CH0O.VKGA'
MPV (WV=/:NG\6:?G357'04@/F35+%Q.<+WJC%9OYR_+WKTG4-#WRD[:HIH6)
M5^7O0![?\)T*: @/H*]%KB_AY;_9](5<8XKM* .=\9C=H$X_V37Q]K-HYU6<
MX_B-?9/BA/,T:9?]FOFV^T3S-1E.W^(T ><FS?TKV/X+6[1WW([US+Z#@_=_
M2O2OA?IWV:[SC'- 'M2_=%+2#H*6@ HHHH *\5^-<1DM.!VKVJO+_BC9_:K;
M&,T ?+WV-]Q^6G)9OYB\=Z[H:%EONTXZ%M=?E[T =G\.8&58LCTKWJU_X]T^
ME>4>"-.\F.,XKUF 8A4>U $E%%% !4<_^I?Z5)3)>8F^E 'SY\1X6>YEP/6O
M%Y[-_.;CO7T5XTT[SYY#BO,9]!_>-\O>@#E?#]FXU*,X[U],> 8RD29]*\?T
M;1-EZAV]Z]R\(VWDQKQVI".RHHHIC(9X1*A4U@7^B1/"YV]O2NEJ*9-T;#VH
M ^7O'.BLE])M3C->;S6$BN?EKZ9\5^'A</(^SK[5Y;J/AW8[?)W]*2$CS%K5
ME&2*AQS79ZGI/DV[-MKCI$(D(QWI@Q#TIHI2#CI2!3Z4 Q:>L1?H*9@^E;6D
M69G/2@$4K>Q=W'RUWOA31F>1-R]ZFTGP_P";(OR_I7IWASPV(MIV?I0,ZSPU
MHL<=FC;><>E=7#$(Q@5#IT(AME7'05<H **** &M]VO!_C'&SOQ7O#?=KR#X
MG67VANF: /F^6V?S.E>L_#.%EBY%<I)I'[W[M>E^ M/\J/I0!U^PT5H?9_:B
M@#S&^TIHX\X-8[1^5P:]=UO10D!.VO,=7MC%*0!7OT*W.CAG"QF(WS4\]:@7
M(:IQR*ZF9B-TI5^[330#206T'+P:1NM*>!3*+@AS#BEM96CN%Y[T@YIN-KYH
M\@/3O#6K"+;N:O0+/45G48(KP*VU5K<C#8KT3PSJQF1<M7F8G#_:.FG/H>F*
M<C-.JK;2AXEYJU7EM6.D****0!1110 4444 8'B*;RH#SVKP_P 17!>^//>O
M8?&4OEVQ^E>)ZJWF71/O7KX".ESDKN[L5HZ=_%3%X%+7H]3&P]NE'1:0<T-0
MQ O6@]<TVG_PYH!Z".:<J[ABH0=QK0LH"\@&*&[*XEJ%GIC2RJ0.]>X^#X#!
MIBJ?2N,\/:.)64E:]*TZV%O % KR<;6YERG71CU+M%%%>:= 4444 %%%% !1
M110 4444 %4[JV61#D"KE-89% 'GWB#25DSA?TKSS7/#Y>W8!?TKW&\L1-VK
M&N] 65"-E 'S)+X7E\UOE/7TIG_"+R_W#7T*W@]"Q/EC\J3_ (0Y/^>8_*@#
MY['A:7/W#^5;6C^&I%N%)4_E7M7_  AR?\\Q^56K;PJD3@^6/RH$SC]/T/:4
MROZ5Z9HFGI':K\HID.C*F/EZ5N6L/E1@8H&2QQA!P*>1D4M% '#^,]/%Q"WR
M]J^<?%&BLE[(VT]:^L]4LQ<1,,=J\=\8>'P!(X3]* /!A9-D\4JVC*W KKDT
MD^8WR]Z/[)._[M &]X NFM9%#'O7T5H<XELD.>U?-6G(UE<1@<<U] >$9C)I
ML9/I0!UG45GZC;+)"<BKXZ4V5=RXH \OU[1PZOA?TKR?6_#;O.^%/Y5](W>F
MB4'Y:YVZ\+K*Y.S]* /F\^%I<_</Y4?\(M+_ '#^5?0G_"')_P \Q^5'_"')
M_P \Q^5 'AFG>&9%E7*'KZ5Z_P"#]%\HQ[E_2MJ#PFB,#Y8_*NDTW2Q;;<+C
M% &D+=4M2 .U>=:WI/FW;MMZFO3R,ICVK&N=-$KDXH \T31.#\OZ5?T+2/)U
M$-M[UVHT@#^&I;73!%-NVT :MLNV,#VJQ347 Q3J "J-_;B6(@BKU,D7<N*
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MU)M"L1#C(KI ,"H((!%TJQ7C3ES.YU15D%%%%04%%%% !1110 4444 %%%%
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MU.HH C\I?2CR5]*DHH C\E?2E$:CM3Z* $ Q01FEHH ;M%&P4ZB@! ,4M%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5T=%*?<],!S2U6M9O-C4^HJS7DM6.H****0'%>.?^/4_2O&KT?O2:]E\<_\
M'J?I7C=Z?WIKV\#\!QU_B*RBG9[4U:">:[>IB*>*9@DTK-FK]C:&9@,=:4G9
M"L:OANP^TR@%<\UZCI&D"(*VVN?\+:2865BM>BVT02,<5Y&*K7EH=E*&A-&N
MU *?117GFX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0C-4[^ /;.,
M=JNTR1=R$4T[,3/'/$FD$LY"]ZX2YB-O)M/%>[ZWIBO&QQ7COB.R:*[.!WKW
M,)5YE8Y*D+&2&W"G=L5'&I'44\_>KKL8^0*,&@C-.;@4#E:%J&Q'0:<O6@_>
MHZC(]N*120^:E8<4@7C--L2V.E\/WIBD&37IVCZJ'"KNZUXI:7!B>NPT'5#]
MIC!;O7#BJ/-J:PE8[/QJ^;+/M7C-V/,NMOJ:]9\5W ETU<'/RUYE!:M+J"\'
MK1@_=@.KK(U] TDLZG;7K^@V@BM ".U<[X=TH"-"5[5VUO$(D %<6+J\SL;4
MX6U)0H%.HHKA-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %-9 13J* .:\0V0EA( [5YC<:(Q
MU(-M/6O:+JW$RXQ6,^B*9@VT5V4:_(K&<X7*.@6 CC3([5UL485>E5K6T$('
M%71P*PJ3YF4E86BBBLB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #%)M%+10 F!2T44 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
7 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MTKP[K$NJ>-?$;WOB72["'Q%=6=U'IO\ :*V,/V>3\K/^#U;_ )2F_ /_ +,
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M^%_".K>/?$.@^#+&._O])\':'+:0:MXAO(Y)H%CTZQGO[**:3>6\RYA1$9G
MK^V*[^*/@3X_?L<?\'>'COX.W=OXD\*^(OC[X9\1Z+<:(/M:ZMX=TGQ)JMK?
M>-;>*W#2'0M9;PQK_B.+4F18'T^.[O)'5()V3\R?^#26">3]N']JR9()GA@_
M8!^.GGS)%(\,!EUSP(L0GE53'"96!6(2,ID96";BI  /PW_9:_X)J_MZ?MKZ
M7?Z_^RS^RI\8/C+X8TRYEL;[Q?X:\,R6_@NWOX%=I=.;QCK<NE>&'U*,1N&T
M^/57O0XV>1O^6O,?CS^QW^U)^R_\4]+^"7[0?P'^)7PD^*FO2:?'X?\ !OC/
MPW>:9J7B/^UKN/3]-E\-S%9+#Q#:WM]-'9P7FC7E]:O=.(/.\SY:_I[_ &9?
MAE\*OV%_^"37[*7QG_X*'?\ !17_ (*"?#;X,_M<>,?B)\1/V:_V/?V!]?M_
M !$.FRV6G^,/&'Q'\::A# ^L-?0S>&M870VU+2M)T5]6TV738O$&I:CJTVD?
M;?\ P4$\9_L^?M*_\$6/^";'QP^$/Q=_:)_:0TKX;_\ !37X=?#_ ,!_&?\
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M?VP__H@J_?ZB@#\ ?^(7'_@A1_T8U_YLS^V'_P#1!4?\0N/_  0H_P"C&O\
MS9G]L/\ ^B"K]_J* /P!_P"(7'_@A1_T8U_YLS^V'_\ 1!4?\0N/_!"C_HQK
M_P V9_;#_P#H@J_?ZB@#\@?V7/\ @@K_ ,$GOV+?CMX&_:7_ &:/V4_^%;?&
MWX:_\)-_PA7C7_A>?[27C'^Q?^$Q\'>(? 'B/_BG/'WQB\5>$M1_M'PEXJU[
;2?\ B;:#?_8_M_V^P^RZG:V=Y;_K]110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
